Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 18

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

5DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Nx-13, 2389235-01-0, Amelenodor [inn], Nx-13 free base, Unii-dvh35h3hdb, Dvh35h3hdb

Molecular Formula

C₂₄H₂₁N₃O₃

Molecular Weight

399.4 g/mol

InChI Key

OPUQKVNCXCWRLR-UHFFFAOYSA-N

1 2D Structure

NX-13

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[3,5-bis[(6-methylpyridin-2-yl)oxy]phenoxy]-6-methylpyridine

2.1.2 InChI

InChI=1S/C24H21N3O3/c1-16-7-4-10-22(25-16)28-19-13-20(29-23-11-5-8-17(2)26-23)15-21(14-19)30-24-12-6-9-18(3)27-24/h4-15H,1-3H3

2.1.3 InChI Key

OPUQKVNCXCWRLR-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=NC(=CC=C1)OC2=CC(=CC(=C2)OC3=CC=CC(=N3)C)OC4=CC=CC(=N4)C

2.2 Synonyms

2.2.1 MeSH Synonyms

1. 1,3,5-tris (6-methylpyridin-2-yloxy) Benzene

2. Nx-13

2.2.2 Depositor-Supplied Synonyms

1. Nx-13

2. 2389235-01-0

3. Amelenodor [inn]

4. Nx-13 Free Base

5. Unii-dvh35h3hdb

6. Dvh35h3hdb

7. Schembl22061849

8. 1,3,5-tris((6-methylpyridin-2-yl)oxy)benzene

9. 2,2',2''-(1,3,5-benzenetriyltris(oxy))tris(6-methylpyridine

10. 2,2',2''-(benzene-1,3,5-triyltris(oxy))tris(6-methylpyridine)

11. Pyridine, 2,2',2''-(1,3,5-benzenetriyltris(oxy))tris(6-methyl-

2.3 Create Date

2020-06-27

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₁N₃O₃
Molecular Weight	399.4 g/mol
XLogP3	5.5
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	6
Exact Mass	399.15829154 g/mol
Monoisotopic Mass	399.15829154 g/mol
Topological Polar Surface Area	66.4 Å²
Heavy Atom Count	30
Formal Charge	0
Complexity	439
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find NX-13 manufacturers, exporters & distributors on PharmaCompass

NX-13

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 18

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

5DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?